Does circulating erythropoietin reflect progression of IgA nephropathy?: Comparison with urinary N-acetyl-β-D-glucosaminidase

被引:18
|
作者
Machiguchi, T
Yoshida, H
Yonemoto, S
Minakata, T
Nomura, K
Muso, E
Tamura, T
Sasayama, S
机构
[1] Kitano Hosp, Inst Med Res, Div Nephrol, Kita Ku, Osaka 5300026, Japan
[2] Himeji Natl Hosp, Dept Internal Med, Himeji, Hyogo, Japan
[3] Kyoto Univ, Dept Cardiovasc Med, Kyoto 606, Japan
关键词
anaemia; erythropoietin; glomerulosclerosis; IgA nephropathy; N-acetyl-beta-D-glucosaminidase; tubulointerstitial damage;
D O I
10.1093/ndt/14.3.635
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Recent reports describe that erythropoietin (Epo) is produced by peritubular interstitial fibroblast-like cells in response to a hypoxic stimulus. We studied serum Epo levels as a possible marker of tubulointerstitial damage in the progression of IgA nephropathy (IgAN), in comparison with urinary (u-) levels of N-acetyl-beta-D-glucosaminidase (NAG), which is mainly derived from proximal tubular cells and is used as a marker of tubular damage. Methods. Thirty-eight patients with IgA nephropathy (IgAN) with relatively preserved renal function (serum creatinine: sCr, 0.5-2.2mg/dl) were examined. The severity of glomerulosclerosis and interstitial fibrosis of the renal biopsy tissue was expressed by semiquantitative grading scores. Clinical parameters including serum creatinine (sCr), blood pressures, and 24-h proteinuria levels were obtained at the renal biopsy. Epo was measured by a radioimmunoassay (RIA) of sera obtained in the morning and u-NAG was measured by colorimetric method of 24-h urine samples. Results. The mean Epo level of the patients ( 17.7 +/- 6.3 mU/ml) was not different from the control level (19.3 +/-3.7 mU/ml). There were no significant correlations between Epo levels and red blood cell (RBC) counts, haematocrit (Hct), or haemoglobin (Hb) levels. The mean u-NAG level of the patients (6.7 +/- 6.2 U/gCr) was significantly higher than the control level (1.9+/-0.5 U/gCr). There was an inverse quantitative correlation between Epo and u-NAG levels in the patients (P<0.02). The u-NAG levels showed quantitative positive correlations with sCr (P<0.001), u-proteins (P<0.001), systolic (SBP) (P<0.001), and diastolic blood pressures (DBP) (P<0.05). Conversely, Epo levels were inversely correlated with sCr, SEP and DBP (each P<0.05). The patients with higher u-proteins (> 2.0 g/day) showed significantly decreased Epo levels (P<0.05) than those with lower u-proteins (<2.0 g/day). The both scores of glomerulosclerosis and interstitial fibrosis were positively correlated with the u-NAG levels (each P<0.001), but were not correlated with the Epo levels. Conclusions, The significant correlation between u-NAG and serum Epo levels suggests that tubular damage and interstitial cell dysfunction are associated each other in the progression of IgAN. Serum Epo levels bearing inverse correlations with sCr, blood pressure levels and heavy proteinuria seem to reflect clinical severity of IgAN, whereas u-NAG can be more useful progression marker of IgAN bearing correlations with both clinical and histological findings.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 50 条
  • [31] CHITINASE BUT N-ACETYL-β-D-GLUCOSAMINIDASE PRODUCTION CORRELATES TO THE BIOMASS DECLINE IN PENICILLIUM AND ASPERGILLUS SPECIES
    Pusztahelyi, Tuende
    Pocsi, Istvan
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2014, 61 (02) : 131 - 143
  • [32] Benchmark dose for cadmium exposure and elevated N-acetyl-β-d-glucosaminidase: a meta-analysis
    Liu, CuiXia
    Li, YuBiao
    Zhu, ChunShui
    Dong, ZhaoMin
    Zhang, Kun
    Zhao, YanBin
    Xu, YiLu
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2016, 23 (20) : 20528 - 20538
  • [33] N-acetyl-β-D-glucosaminidase and β2-microglobulin:: Prognostic markers in idiopathic nephrotic syndrome
    Fede, C
    Conti, G
    Chimenz, R
    Ricca, M
    JOURNAL OF NEPHROLOGY, 1999, 12 (01) : 51 - 55
  • [34] Increased excretion of N-acetyl-β-D-glucosaminidase and β2-microglobulin in gestational week 30
    Hayashi, M
    Tomobe, K
    Hirabayashi, H
    Hoshimoto, K
    Ohkura, T
    Inaba, N
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (03) : 168 - 172
  • [35] Activity and isoenzyme profile of N-acetyl-β-D-glucosaminidase in urine from workers exposed to cadmium
    Tassi, C
    Abbritti, G
    Mancuso, F
    Morucci, P
    Feligioni, L
    Muzi, G
    CLINICA CHIMICA ACTA, 2000, 299 (1-2) : 55 - 64
  • [36] Inactivation kinetics of formaldehyde on N-acetyl-β-d-glucosaminidase from Nile tilapia (Oreochromis niloticus)
    Zhang, Wei-Ni
    Bai, Ding-Ping
    Lin, Xin-Yu
    Chen, Qing-Xi
    Huang, Xiao-Hong
    Huang, Yi-Fan
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 2014, 40 (02) : 561 - 569
  • [37] Urinary N-acetyl-β-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts
    Kotanko, P
    Margreiter, R
    Pfaller, W
    NEPHRON, 2000, 84 (03) : 228 - 235
  • [38] Change in urinary N-acetyl-β-D-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus
    Ouchi, Motoshi
    Oba, Kenzo
    Ohara, Makoto
    Igari, Yoshimasa
    Futami-Suda, Shoko
    Ishii, Kazuhito
    Aoyama, Junya
    Onishi, Tetsuro
    Tsunoda-Kubota, Misako
    Yamashita, Hidetoshi
    Suzuki, Tatsuya
    Nakano, Hiroshi
    CLINICA CHIMICA ACTA, 2014, 433 : 88 - 92
  • [39] Diagnostic value of urinary alanine aminopeptidase and N-acetyl-β-D-glucosaminidase in comparison to α1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients
    Holdt-Lehmann, B
    Lehmann, A
    Korten, G
    Nagel, HR
    Nizze, H
    Schuff-Werner, P
    CLINICA CHIMICA ACTA, 2000, 297 (1-2) : 93 - 102
  • [40] Evaluation of N-acetyl-β-D-glucosaminidase as a prognostic marker for diabetic nephropathy in type 2 diabetics: systematic review and meta-analysis
    Bitencourt, Augusto dos Santos
    Vargas Filho, Regis Leaes
    Prestes, Gabriele da Silveira
    Uggioni, Maria Laura Rodrigues
    Marcal, Fernanda
    Colonetti, Tamy
    da Rosa, Maria Ines
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (05) : 1651 - 1661